VILDAGLIPTINE TEVA 50 mg, tablet 60 tablets
Active ingredients: Vildagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VILDAGLIPTINE TEVA 50 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68648605CIP73024994CIP133400930249949Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VILDAGLIPTINEcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.